NMPA Approval

Tirofiban Hydrochloride Concentrated Solution for Injection

Approval Number

国药准字H20193062

Company天津红日药业股份有限公司

Registration Date

November 3, 2023

Drug Information

Generic Name

盐酸替罗非班注射用浓溶液

Dosage Form

注射剂

Strength

50ml∶12.5mg（以替罗非班计）

Drug Type

化学药品

Registration Date

November 3, 2023

Company Information

Applicant Company

Company Name天津红日药业股份有限公司

Company Address

天津新技术产业园区武清开发区泉发路西

Manufacturing Company

Company Name天津红日药业股份有限公司

Company Address

天津新技术产业园区武清开发区泉发路西；天津新技术产业园区武清开发区源泉路17号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸替罗非班注射用浓溶液 - NMPA 批准文号 | MedPath